… Barth syndrome has emerged in the last two decades as a unique inborn error of
metabolism, involving cardiolipin and probably other membrane phospholipids. Symptoms as …

X‐linked cardioskeletal myopathy, neutropenia and abnormal mitochondria (MIM 302060) (synonyms:
Barth syndrome, 3‐methylglutaconic aciduria type II, endocardial fibroelastosis …

The Rosetta software for macromolecular modeling, docking and design is extensively used
in laboratories worldwide. During two decades of development by a community of …

… myopathy and neutropenia (Barth syndrome, MIM 302060) have … We show that this defect
was only observed in Barth syndrome … product, which is mutated in Barth syndrome patients, is …

… P values quantified results of confirmatory or explorative tests or imbalances between …
the Wilcoxon-Mann-Whitney test showed a difference in favor of octreotide LAR (P .0079). …

Barth syndrome (BTHS) is an X-linked recessive disorder that is biochemically characterized
by low cellular levels of the mitochondrial phospholipid cardiolipin (CL). Previously, we …

… Paul Barth and Randy Bean are the cofounders and managing partners of NewVantage
Partners, a Boston-based management consulting firm. Comment on this article at http://…

An X-linked recessive disease is reported in a large pedigree. The disease is characterised
by a triad of dilated cardiomyopathy, neutropenia and skeletal myopathy. The untreated …

The IncPα promiscuous plasmid (R18, R68, RK2, RP1 and RP4) comprises 60,099 bp of
nucleotide sequence, encoding at least 74 genes. About 40 kb of the genome, designated the …

… However, we found a significant difference in the functional and knee scores between the
morbidly obese patients and the control group (p < 0.00005) in the current study; this …